The expression and purification of truncated tau was performed, as previously described [43]. The labeling of recombinant tau was performed using Alexa Fluor™ 546 Protein Labeling Kit (#A10237; Thermo-Scientific, Bratislava, Slovakia), according to the manufacturer’s instructions. The in vitro aggregation of recombinant truncated tau protein (aa151-391, based on longest tau isoform tau 40) was performed using heparin (Sigma) as an inducer at a final concentration of 25 μM in 1× PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4) overnight at 37 °C, as previously described and characterized [44]. Post incubation, the sample was centrifuged at 100,000× g for 1h at room temperature, and the pellet was re-suspended in 1× PBS, sonicated for 5 s at 20% power output using an MS72 probe of a Bandello Sonopuls Sonifier (Bandelin, Berlin, Germany), and stored as 1 μM aliquots at −80 °C. The oligomerization of the tau protein was verified by immunoblotting and electron microscopy (Supplementary Figure S2a,b). For the examination of tau uptake by astrocytes, cells were plated on 8-well Lab-Tek slides (25,000 cells/well), incubated with labeled monomeric (4 µM)/aggregated tau (1 µM), and washed and examined using LSM 710 confocal microscope (Carl-Zeiss, Jena, Germany). Images were obtained using the Zen software system (Carl-Zeiss, Jena, Germany) and fluorescent intensities were measured using Fiji (ImageJ 2.0.0). For the compartmentalization study, SiR-lysosome kit—Live cell lysosome probe (Spirochrome, Stein am Rhein, Switzerland) was used according to the manufacturer’s instructions.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.